223 related articles for article (PubMed ID: 19679043)
1. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.
Kato I; Cichon M; Yee CL; Land S; Korczak JF
Cancer Epidemiol; 2009 Jul; 33(1):24-30. PubMed ID: 19679043
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 and CYP1B1 polymorphisms and their association with estradiol and estrogen metabolites in women who are premenopausal and perimenopausal.
Sowers MR; Wilson AL; Kardia SR; Chu J; McConnell DS
Am J Med; 2006 Sep; 119(9 Suppl 1):S44-51. PubMed ID: 16949388
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
6. Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients.
Ociepa-Zawal M; RubiĆ B; Filas V; Breborowicz J; Trzeciak WH
Ginekol Pol; 2009 Nov; 80(11):819-23. PubMed ID: 20088394
[TBL] [Abstract][Full Text] [Related]
7. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
8. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
9. Potential differences in breast cancer risk factors based on CYP1A1 MspI and African-American-specific genotypes.
Zhu K; Hunter S; Payne-Wilks K; Sutcliffe C; Bentley C; Roland CL; Williams SM
Ethn Dis; 2006; 16(1):207-15. PubMed ID: 16599372
[TBL] [Abstract][Full Text] [Related]
10. Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.
Cote ML; Wenzlaff AS; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Lung Cancer; 2007 Mar; 55(3):255-62. PubMed ID: 17174438
[TBL] [Abstract][Full Text] [Related]
11. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer risk and polymorphisms involved in estrogen catabolism.
Holt SK; Rossing MA; Malone KE; Schwartz SM; Weiss NS; Chen C
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):481-9. PubMed ID: 17372243
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
15. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Jul; 122(2):459-69. PubMed ID: 20035380
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
Breast Cancer Res; 2004; 6(4):R460-73. PubMed ID: 15217514
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
Sangrajrang S; Sato Y; Sakamoto H; Ohnami S; Laird NM; Khuhaprema T; Brennan P; Boffetta P; Yoshida T
Int J Cancer; 2009 Aug; 125(4):837-43. PubMed ID: 19415745
[TBL] [Abstract][Full Text] [Related]
20. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features.
Han W; Kang D; Park IA; Kim SW; Bae JY; Chung KW; Noh DY
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):124-30. PubMed ID: 14734460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]